Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

14 Aug 2012 10:42

Tate & Lyle PLC - 14 August 2011

Director/PDMR Shareholding

Tate & Lyle PLC (the "Company") was informed yesterday that on 13 August 2012 a grant of options and awards over the Company's ordinary shares of 25 pence each was made in London under the Tate & Lyle Group Bonus Plan ("GBP") to the Executive Directors and Persons Discharging Managerial Responsibilities ("PDMR") as detailed in the table below:

Name Role No. of shares subject to option No of shares subject to award
Javed Ahmed Executive Director 2,010 -
Tim Lodge Executive Director 1,131 -
Robert Gibber PDMR 984 -
Rob Luijten PDMR 666 -
Karl Kramer PDMR - 824
Matt Wineinger PDMR - 1,012

No consideration is payable for the grant or exercise of the options or awards. Further information on the GBP is provided in the Annual Report 2012.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FSA's Disclosure and Transparency Rules.

Lucie GilbertCompany Secretary14 August 2012

Copyright Business Wire 2012

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.